tiprankstipranks
Trending News
More News >
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market

Belite Bio, Inc. ADR (BLTE) Income Statement

Compare
49 Followers

Belite Bio, Inc. ADR Income Statement

Last quarter (Q2 2025), Belite Bio, Inc. ADR's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Belite Bio, Inc. ADR's net income was $-16.32M. See Belite Bio, Inc. ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ -198.00K$ -30.00K$ 0.00
Operating Expenses
$ 40.00M$ 31.67M$ 12.82M$ 9.80M$ 5.74M
Depreciation and Amortization
$ 449.00K$ 399.00K$ 198.00K$ 30.00K$ 17.00K
EBITDA
$ -35.67M$ -31.20M$ -12.43M$ -9.64M$ -5.73M
Operating Income
$ -40.00M$ -31.67M$ -12.82M$ -9.80M$ -5.74M
Other Income/Expenses
$ 3.86M$ 45.00K$ 173.00K$ 131.00K$ -9.00K
Pretax Income
$ -36.14M$ -31.62M$ -12.65M$ -9.67M$ -5.75M
Net Income
$ -36.14M$ -31.63M$ -12.65M$ -9.67M$ -5.75M
Per Share Metrics
Basic EPS
$ -1.18$ -1.19$ -0.63$ -0.40$ -0.62
Diluted EPS
$ -1.18$ -1.19$ -0.63$ -0.40$ -0.62
Weighted Average Shares Outstanding
30.54M 26.59M 19.98M 24.10M 9.21M
Weighted Average Shares Outstanding (Diluted)
30.54M 26.59M 19.98M 24.10M 9.21M
Currency in USD

Belite Bio, Inc. ADR Earnings and Revenue History